CAN
CLVS

Claraphi Advisory Network’s Clovis Oncology, Inc. CLVS Stock Holding History

Claraphi Advisory Network’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$1K – 1273
2020
Q1 		$1K Buy
+100
New +$802 ﹤0.01% 1142

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Claraphi Advisory Network's CLVS Position: Q2 2020 in Review

Claraphi Advisory Network sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

Claraphi Advisory Network first reported a position in CLVS in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Claraphi Advisory Network reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Claraphi Advisory Network sold 100 Clovis Oncology, Inc. shares in Q2 2020, an estimated $1K.
  • Claraphi Advisory Network first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 1 quarter.
  • Claraphi Advisory Network's Clovis Oncology, Inc. position peaked at $1K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.